Continuous micro-current stimulation to upgrade methanolic wastewater biodegradation and biomethane recovery in an upflow anaerobic sludge blanket (UASB) reactor

The dispersion of granules in upflow anaerobic sludge blanket (UASB) reactor represents a critical technical issue in methanolic wastewater treatment. In this study, the potentials of coupling a microbial electrolysis cell (MEC) into an UASB reactor for improving methanolic wastewater biodegradation, long-term process stability and biomethane recovery were evaluated. The results indicated that coupling a MEC system was capable of improving the overall performance of UASB reactor for methanolic wastewater treatment. The combined system maintained the comparatively higher methane yield and COD removal efficiency over the single UASB process through the entire process, with the methane production at the steady-state conditions approaching 1504.7 ± 92.2 mL-CH4 L−1-reactor d−1, around 10.1% higher than the control UASB (i.e. 1366.4 ± 71.0 mL-CH4 L−1-reactor d−1). The further characterizations verified that the input of external power source could stimulate the metabolic activity of microbes and reinforced the EPS secretion. The produced EPS interacted with Fe2+/3+ liberated during anodic corrosion of iron electrode to create a gel-like three-dimensional [-Fe-EPS-]n matrix, which promoted cell-cell cohesion and maintained the structural integrity of granules. Further observations via SEM and FISH analysis demonstrated that the use of bioelectrochemical stimulation promoted the growth and proliferation of microorganisms, which diversified the degradation routes of methanol, convert the wasted CO2 into methane and accordingly increased the process stability and methane productivity

Puerarin alleviates osteoporosis in rats by targeting the JAK2/STAT3 signaling pathway

Osteoporosis (OP) is a common chronic progressive bone disease that increases fracture risk in postmenopausal women. Research suggests that puerarin (Pue) may be an effective treatment for OP. This study examined the effects and underlying mechanisms of Pue in treating postmenopausal osteoporosis (PMOP) in rats. Sprague–Dawley (SD) rats underwent bilateral ovariectomy to simulate PMOP and were then treated with subcutaneous injections of Pue. Bone mineral density (BMD) was measured using a bone densitometer. Micro-CT scans assessed femur bone structure and various parameters were calculated: bone volume fraction (BV/TV), bone surface density (BS/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), and bone surface area-to-bone volume ratio (BS/BV). Hematoxylin-eosin (HE) staining was employed to observe femoral tissue pathology. Serum levels of bone formation metabolism-related markers—osteocalcin (OC), bone alkaline phosphatase (BALP), and procollagen type I N-terminal propeptide (PINP)—were measured via enzyme-linked immunosorbent assay (ELISA). The protein expression levels of the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway in bone tissue were evaluated using Western blotting assay. The results showed improved bone density and reduced bone loss in rats treated with Pue. There were also significant increases in serum levels of OC and BALP, indicating enhanced osteogenesis. Furthermore, there was a decrease in activation of the JAK2/STAT3 pathway in femoral tissue, suggesting a pathway inhibition. These findings indicate that Pue may combat osteoporosis by promoting osteogenesis and inhibiting activation of the JAK2/STAT3 pathway activation

An analytical model for the accretion of dark matter subhalos

An analytical model is developed for the mass function of cold dark matter subhalos at the time of accretion and for the distribution of their accretion times. Our model is based on the model of Zhao et al. (2009) for the median assembly histories of dark matter halos, combined with a simple log-normal distribution to describe the scatter in the main-branch mass at a given time for halos of the same final mass. Our model is simple, and can be used to predict the un-evolved subhalo mass function, the mass function of subhalos accreted at a given time, the accretion-time distribution of subhalos of a given initial mass, and the frequency of major mergers as a function of time. We test our model using high-resolution cosmological $N$-body simulations, and find that our model predictions match the simulation results remarkably well. Finally, we discuss the implications of our model for the evolution of subhalos in their hosts and for the construction of a self-consistent model to link galaxies and dark matter halos at different cosmic times.Comment: 14 pages, 10 figures (caption for figure 10 fixed). Accepted for publication in Ap

SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.

Activated Wnt/β-catenin pathway is a key genetic event in liver cancer development. Solute carrier (SLC) transporters are promising drug targets. Here, we identify SLC13A3 as a drug-targetable effector downstream of β-catenin in liver cancer. SLC13A3 expression is elevated in human liver cancer samples with gain of function (GOF) mutant CTNNB1, the gene encoding β-catenin. Activation of β-catenin up-regulates SLC13A3, leading to intracellular accumulation of endogenous SLC13A3 substrates. SLC13A3 is identified as a low-affinity transporter for glutathione (GSH). Silencing of SLC13A3 downregulates the leucine transporter SLC7A5 via c-MYC signaling, leading to leucine depletion and mTOR inactivation. Furthermore, silencing of SLC13A3 depletes GSH and induces autophagic ferroptosis in β-catenin-activated liver cancer cells. Importantly, both genetic inhibition of SLC13A3 and a small molecule SLC13A3 inhibitor suppress β-catenin-driven hepatocarcinogenesis in mice. Altogether, our study suggests that SLC13A3 could be a promising therapeutic target for treating human liver cancers with GOF CTNNB1 mutations

Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy

Recently, fibroblast activation protein (FAP), an overexpressed transmembrane protein of activated fibroblast in pulmonary fibrosis, has been considered as the new target for diagnosing and treating pulmonary fibrosis. In this work, mesoporous polydopamine (MPDA), which is facile prepared and easily modified, is developed as a carrier to load antifibrosis drug pirfenidone (PFD) and linking FAP inhibitor (FAPI) to realize lesion-targeted drug delivery for pulmonary fibrosis therapy. We have found that PFD@MPDA-FAPI is well biocompatible and with good properties of antifibrosis, when ICG labels MPDA-FAPI, the accumulation of the nanodrug at the fibrosis lung in vivo can be observed by NIR imaging, and the antifibrosis properties of PFD@MPDA-FAPI in vivo were also better than those of pure PFD and PFD@MPDA; therefore, the easily produced and biocompatible nanodrug PFD@MPDA-FAPI developed in this study is promising for further clinical translations in pulmonary fibrosis antifibrosis therapy

Precision measurements of A1N in the deep inelastic regime

We have performed precision measurements of the double-spin virtual-photon asymmetry A1A1 on the neutron in the deep inelastic scattering regime, using an open-geometry, large-acceptance spectrometer and a longitudinally and transversely polarized 3He target. Our data cover a wide kinematic range 0.277≤x≤0.5480.277≤x≤0.548 at an average Q2Q2 value of 3.078 (GeV/c)2, doubling the available high-precision neutron data in this x range. We have combined our results with world data on proton targets to make a leading-order extraction of the ratio of polarized-to-unpolarized parton distribution functions for up quarks and for down quarks in the same kinematic range. Our data are consistent with a previous observation of anA1n zero crossing near x=0.5x=0.5. We find no evidence of a transition to a positive slope in(Δd+Δd¯)/(d+d¯) up to x=0.548x=0.548

Pollution control and resource reuse for alkaline hydrometallurgy of amphoteric metal hazardous wastes

This book provides a comprehensive description of alkaline hydrometallurgy of amphoteric metal hazardous wastes. Topics focus on leaching of zinc and lead hazardous wastes, purification of leach solution of zinc and lead, electrowinning of zinc and lead from purified alkaline solutions, chemical reactions taking place in the production flowsheets, thermodynamic and spent electrolyte regeneration, alkaline hydrometallurgy of low-grade smithsonite ores, recovery of molybdenum and tungsten using ion flotation and solvent extraction processes and their application in chemical synthesis of Nb and Ta inorganic compounds, and industrial scale production of 1500-2000 t/a zinc powder using alkaline leaching–electrowinning processes. Processes described are cost-effective, generate lesser secondary pollutants, and have been applied widely in China. Readers that will find the book appealing include solid waste engineers, environmental managers, technicians, recycling coordinators, government officials, undergraduates and graduate students, and researchers.